A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31)
Clinical trial NCT01049282 · COMPLETED
Trial details
- NCT number
- NCT01049282
- Sponsor
- Statens Serum Institut
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-04-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.